Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kyra Cowan"'
Autor:
Ping Hu, Haiqing Isaac Dai, James Bourdage, Dongli Zhou, Ky Trang, Karey Kowalski, Carlo Bello, Jennifer Hibma, Akash Khandelwal, Kyra Cowan, Jennifer Dong, Karthik Venkatakrishnan, Wei Gao
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 3, Pp n/a-n/a (2024)
Abstract Like other monoclonal antibodies, immune checkpoint inhibitors may be immunogenic in some patients, potentially affecting pharmacokinetics (PKs) and clinical outcomes. In post hoc analyses, we characterized antidrug antibody (ADA) developmen
Externí odkaz:
https://doaj.org/article/c5638b6934e845ae90faad55fc3b822a
Autor:
Philip Timmerman, Matthew Barfield, Kyra Cowan, Luca Ferrari, Michaela Golob, Joanne Goodman, Morten Kall, Anna Laurén, Iain Love, Stuart McDougall, Robert Nelson, Gwenda Pynaert, Roland F Staack, Tom Verhaeghe, Steve White
Publikováno v:
Bioanalysis. 14:1407-1411
In this report, the European Bioanalysis Forum shares the proposals for harmonized implementation of the ICH M10 guideline on bioanalytical method validation and study sample analysis from the ICH M10 workshop. The focus of the discussions was to und
Autor:
Luca Barbero, Andrea Di Ianni, Tiziana Fraone, Piercesare Balestra, Kyra Cowan, Federico Riccardi Sirtori
Major histocompatibility complex-II (MHC-II)-Associated Peptide Proteomics (MAPPs) is a mass spectrometry-based approach, to identify and relatively quantitate naturally processed and presented MHC-II-associated peptides, that could potentially activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cec268cc88dbfcea83759df1f54f17a7
https://doi.org/10.21203/rs.3.rs-1944419/v1
https://doi.org/10.21203/rs.3.rs-1944419/v1
Publikováno v:
Journal of Immunological Methods. 517:113484
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. :115500
Autor:
Connie Sauder, Marc Giband, Rayinder Sardana, Illimar Altosaar, Stefan Dukiandjiev, Xiongying Cheng, Kyra Cowan
Publikováno v:
Plant Cell Reports
The synthesis of two modified genes, Cry IA(b) and CryIA(c), each consisting of 1845 bp, is described in detail. The genes were synthesized using an improved PCR procedure based on recursive principles. The synthetic CryIA(c) gene was put under the c